Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs.
Sci Signal
; 10(462)2017 01 17.
Article
in En
| MEDLINE
| ID: mdl-28096513
Full text:
1
Database:
MEDLINE
Main subject:
T-Lymphocytes, Regulatory
/
Receptors, Tumor Necrosis Factor, Type II
/
Cell Proliferation
/
Antibodies, Monoclonal
Type of study:
Risk_factors_studies
Limits:
Female
/
Humans
Language:
En
Year:
2017
Type:
Article